QT Vascular in US$13.14m convertible debt investment to fund growth
QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into a US$13.14 million convertible debt investment to fund its next growth phase.
This comes less than a month after the company entered into a US$12 million convertible bond investment to further develop its Drug-Coated Chocolate platform.
On Friday, the counter closed down 0.84 per cent, or 0.1 Singapore cent, at S$0.118.
Share with us your feedback on BT's products and services
TRENDING NOW
From legacy to launch: Francis Yeoh and Yeoh Pei Xien on family unity and YTL’s next‑gen ventures
Things to know about DBS’ incoming chairman Anthony Lim
Wealthy Indonesians snap up government bonds as yields near 8%: OCBC
From local AI partnerships to global opportunities: How MNCs help Singapore firms scale